Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas. - Wikidata - awgldk - TriplyDB

Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.

Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.

http://www.wikidata.org/entity/Q34091569

about

Regulation of Desmocollin3 Expression by Promoter Hypermethylation is Associated with Advanced Esophageal Adenocarcinomas.Silencing of glutathione peroxidase 3 through DNA hypermethylation is associated with lymph node metastasis in gastric carcinomas Epigenetics in the Pathogenesis of Esophageal Adenocarcinoma Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma.Glutathione peroxidase 7 has potential tumour suppressor functions that are silenced by location-specific methylation in oesophageal adenocarcinoma.Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine.CHFR: a key checkpoint component implicated in a wide range of cancers.Epigenetic silencing of checkpoint with fork-head associated and ring finger gene expression in esophageal cancer.Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach.Clinicopathological significance of CHFR methylation in non-small cell lung cancer: a systematic review and meta-analysis.Genome-scale methylation analysis of Parkinson's disease patients' brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1.Upregulation of the checkpoint protein CHFR is associated with tumor suppression in pancreatic cancers.Clinicopathological significance of CHFR promoter methylation in gastric cancer: a meta-analysis.

P2860

Q33634990-4514DCFD-BC93-4D3A-9F78-55DF07926724 Q34447015-0EB729EF-1132-4B47-B3EF-691E2D7DAEAD Q35598456-5A97DE06-D88B-45BB-AE2E-8C440D1D7141 Q36725997-9C3B35C9-CDF5-432B-B45B-F718688FE8D6 Q37302875-9F700C69-0D74-4E6B-B1A5-75660BEEFAA2 Q37705684-5F8C19FA-25CD-44A2-8350-72DC3AA2907E Q37967195-49CB8A23-8B89-428B-BBCC-AEDE5C24495B Q42801200-5409BD29-320D-45A5-9688-BE78D69AF1EE Q44522889-A6B5F03C-E6F7-481F-B261-F317907AC430 Q47193635-5B242B23-B643-4558-AB5F-977E99965870 Q48716550-02777472-ED3C-4ACF-A2DC-61E41D3106B5 Q49413106-CC85ADD6-CF00-4A93-93A0-44F4F2AB2B88 Q52728019-7A4A3C04-0B82-4403-84BC-E4433BA924E3

P2860

Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.

http://www.wikidata.org/entity/Q34091569

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.

@ast

Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.

@en

Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.

@nl

type

label

Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.

@ast

Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.

@en

Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.

@nl

prefLabel

Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.

@ast

Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.

@en

Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.

@nl

P1433

Q34091569-D9928F96-979B-4AA8-8511-9218090DF479

P1476

Q34091569-4C39D8AE-BD97-474D-89A3-43C942459E0C

P2093

Q34091569-0B7A13E7-723E-42FC-8842-4F84C4C638AA

Q34091569-1000D1E1-60C7-4FA3-BDE6-16A8D9D4E085

Q34091569-11EFF68E-3711-433B-B0FD-364F1A17813E

Q34091569-748BC0F9-FDD4-484A-8530-D4DD7A2EE270

Q34091569-82DAA332-2380-4919-BF96-DA7EC1B235B2

Q34091569-8C356B1B-B0C7-4EAC-9D17-D2ACE9506184

Q34091569-A03E07C4-E197-4434-913A-24FCADC3A1EC

Q34091569-DB1F1A31-7FDA-446B-A84E-5AA644A94E71

P2860

Q34091569-04E82B09-C4EF-4DAC-B811-1DDFE5715928

Q34091569-069BE9DE-8CC3-400F-8295-419DBE9A8E6E

Q34091569-0EB03EAB-6425-4B72-87C6-56C2E842EEA4

Q34091569-1F0170F6-A816-454A-8909-FA79F8BB8721

Q34091569-20D01526-626A-4D49-B5C5-4A65F542615A

Q34091569-235ECAF1-2486-4B5B-B405-046A16BD587D

Q34091569-26FA3DB6-C21F-4A87-BEBE-53DB32D6AC39

Q34091569-341F3619-4B7C-4409-96FF-EB4F26C93FDF

Q34091569-362240FA-51AA-4C31-9E69-8B393B440108

Q34091569-372F0DA3-FA96-4BE8-BD71-E1C8A88AB36B

P304

Q34091569-6514FF15-203D-47B3-8821-FAACFED6D935

P31

Q34091569-530C1607-5C28-45E2-9E87-ADCA941190B4

P356

Q34091569-50490DF4-D2E7-44C8-8A73-C6BB98791003

P407

Q34091569-1AF10CA9-B5B5-4468-B4CA-F9A91D596439

P433

Q34091569-366346CF-305A-4D4D-9FDF-42A7683861EC

P478

Q34091569-56A38A1C-9875-43E5-8A97-2D489A5609D2

P50

Q34091569-C44EA3F1-B3DE-44EB-889A-6B3B0EBA285F

P577

Q34091569-23A73CB5-0B06-46E5-84D3-1BDBF5988C61

P5875

Q34091569-8FF08492-F796-490A-811F-6F5B64DEDAE1

P698

Q34091569-01CF4253-1994-4CC1-AD4B-D297C1475351

P921

Q34091569-FD9439AD-DA5E-4966-959C-FFA6D23FBEE2

P932

Q34091569-2C6B3A05-28A0-4048-991F-4C10187EC2DD

P356

P1433

P1476

Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.

@en

P2093

Albert Roessner

http://www.w3.org/2001/XMLSchema#string

Arndt Hartmann

http://www.w3.org/2001/XMLSchema#string

Dunfa Peng

http://www.w3.org/2001/XMLSchema#string

Mohammad Razvi

http://www.w3.org/2001/XMLSchema#string

Mohammed Soutto

http://www.w3.org/2001/XMLSchema#string

Petra Ruemmele

http://www.w3.org/2001/XMLSchema#string

Regine Schneider-Stock

http://www.w3.org/2001/XMLSchema#string

Wael El-Rifai

http://www.w3.org/2001/XMLSchema#string

P2860

Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

Chfr defines a mitotic stress checkpoint that delays entry into metaphase

Loss of CHFR in human mammary epithelial cells causes genomic instability by disrupting the mitotic spindle assembly checkpoint

The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition.

Epigenetic inactivation of CHFR in human tumors

Evolution of neoplastic cell lineages in Barrett oesophagus

The fundamental role of epigenetic events in cancer

Promotion of mitosis by activated protein kinase B after DNA damage involves polo-like kinase 1 and checkpoint protein CHFR

Frequent hypermethylation of the 5' CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer

Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer

P304

4033-4042

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.25151

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

Regine Schneider-Stock

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44688665

http://www.w3.org/2001/XMLSchema#string

P698

20564104

http://www.w3.org/2001/XMLSchema#string

P921

P932

2930066

http://www.w3.org/2001/XMLSchema#string